HIV/AIDS

World AIDS Day 2014 - Closing the gap in HIV prevention and treatment services

1 December 2014 – On World AIDS Day 2014, we are releasing a new supplement to the 2013 ARV guidelines, which addresses two important and neglected areas of the HIV response. These include new recommendations on post-exposure prophylaxis (PEP) enabling emergency prevention for those in need, with a single 28-day course of antiretrovirals. Access to PEP can help many people prevent HIV after accidental exposure, especially those who are working in health clinics, or survivors of sexual violence. New recommendations on affordable cotrimoxazole prophylaxis for those living with HIV, and also burdened with malaria and bacterial infections, are also included in the new supplement.

First PROMISE study results confirm WHO recommendations

Mother and child
©UNICEF/SouthAfrica/Schermbrucker/2014

17 November 2014 - The United States National Institute of Allergy and Infectious Diseases (NIAID) published interim results of the PROMISE (Promoting Maternal-Infant Survival Everywhere) study. The PROMISE study aims to determine how best to safely reduce the risk of HIV transmission from infected pregnant women to their babies during pregnancy and after delivery and assure the benefits of antiretroviral therapy (ART) for the health of the mother. Started in 2010, the study has enrolled more than 3500 HIV-infected pregnant or post-partum women in India, Malawi, South Africa, Tanzania, Uganda, Zambia and Zimbabwe.

WHO consultation on PrEP adherence

15 October - WHO organized a small consultation of key experts on the topic of HIV pre-exposure prophylaxis (PrEP) adherence to discuss how to consider and measure PrEP adherence beyond the context of clinical trials. The consultation took place on 8 June 2014 in Miami, USA. The report captures the process of the consultation, key agreements and next action points, and the list of participants.

Top stories

fact buffet

11.7 million At the end of 2013, 11.7 million people had access to antiretroviral therapy in low- and middle-income countries.

Fact sheet on HIV/AIDS

35 millionAt the end of 2013, 35 million people were living with HIV.

Online Q&A about HIV/AIDS

28 million Over 28 million people are eligible for antiretroviral therapy, under WHO 2013 consolidated ARV guidelines.

10 facts on HIV

Global Health Sector Strategy on HIV/AIDS 2011-2015: Let’s do what’s right for everyone

Global Hepatitis Programme

Contact us

World Health Organization
HIV/AIDS Department
20, Avenue Appia
CH-1211 Geneva 27
Switzerland
Email: hiv-aids@who.int